Loading clinical trials...

Visual (Path)Ways in Multiple Sclerosis - Part II | Clinical Trials | Clareo Health

RECRUITINGNANCT06776224

Visual (Path)Ways in Multiple Sclerosis - Part II

Multiple sclerosis (MS) is an inflammatory demyelinating and degenerative disease of the central nervous system. The mechanisms of neuro-axonal loss remain incompletely elucidated. An acute demyelinat...

Lead sponsor: University Hospital, Lille•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

OUTTERYCK Olivier, PhD

CONTACT

03.20.44.64.69 olivier.outteryck@chru-lille.fr

COURTOIS Brigitte

CONTACT

03.20.44.41.45 DRS.PROMOTION@CHU-LILLE.FR

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment64

Start dateJan 2025

Last updatedJan 31, 2025

Condition

Multiple Sclerosis, Optic Neuritis, Demyelinating Disease

Locations shown

Direction de la Recherche et de l'innovation (DRI) 6 rue Professeur Laguesse

Lille

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 31, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions